- Home
- USB vs MCK Comparison
USB vs MCK Comparison
Compare USB & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USB | MCK |
|---|---|---|
| Founded | 1863 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.3B | 101.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | USB | MCK |
|---|---|---|
| Price | $54.31 | $828.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 13 |
| Target Price | $54.53 | ★ $882.69 |
| AVG Volume (30 Days) | ★ 9.0M | 767.7K |
| Earning Date | 01-20-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.82% | 0.40% |
| EPS Growth | 34.24 | ★ 66.19 |
| EPS | 4.37 | ★ 32.12 |
| Revenue | $26,013,000,000.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $14.92 | $14.87 |
| Revenue Next Year | $4.52 | $8.33 |
| P/E Ratio | ★ $12.47 | $25.85 |
| Revenue Growth | 4.48 | ★ 17.23 |
| 52 Week Low | $35.18 | $565.75 |
| 52 Week High | $55.15 | $895.58 |
Technical Indicators
Market Signals| Indicator | USB | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 68.97 | 51.83 |
| Support Level | $54.42 | $823.34 |
| Resistance Level | $55.15 | $833.72 |
| Average True Range (ATR) | 0.74 | 11.80 |
| MACD | -0.06 | 1.65 |
| Stochastic Oscillator | 75.84 | 83.69 |
Price Performance
Historical ComparisonAbout USB U.S. Bancorp
With assets of around $695 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in Midwestern and Western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, and wealth services.
About MCK McKesson Corporation
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.